{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:24Z","timestamp":1759366404615,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.revmed.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T04:57:37Z","timestamp":1214542657000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surcharges en fer d\u2019origine g\u00e9n\u00e9tique et h\u00e9patosid\u00e9rose dysm\u00e9tabolique"],"prefix":"10.1016","volume":"30","author":[{"given":"M.","family":"Ruivard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"22974","DOI":"10.1074\/jbc.M602098200","article-title":"Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression","volume":"281","author":"Harrison-Findik","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2005.07.001","article-title":"Iron, oxidative stress and human health","volume":"26","author":"Puntarulo","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/35001596","article-title":"Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter","volume":"403","author":"Donovan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalisation","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.revmed.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice","volume":"98","author":"Nicolas","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2008.05.004_bib8","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.072632499","article-title":"Severe iron deficiency anemia in transgenic mice expressing liver hepcidin","volume":"99","author":"Nicolas","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis-a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/bcmd.1998.0183","article-title":"Frequency of the C282Y mutation of hemochromatosis in five French populations","volume":"24","author":"Mercier","year":"1998","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.revmed.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ajcn\/81.4.814","article-title":"Iron absorption in male C282Y heterozygotes","volume":"81","author":"Roe","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.revmed.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.327.7407.132","article-title":"Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians","volume":"327","author":"Coppin","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2008.05.004_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G \u2192 A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.05.004_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc05-1592","article-title":"Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study","volume":"29","author":"Acton","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1530\/eje.1.02152","article-title":"Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department","volume":"154","author":"Vantyghem","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/jhep.2002.35343","article-title":"Non-invasive prediction of cirrhosis in C282Y-linked hemochromatosis","volume":"36","author":"Beaton","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-138-8-200304150-00008","article-title":"Serum ferritin levels predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis","volume":"138","author":"Morrison","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinte.166.3.294","article-title":"Screening for hemochromatosis in asymptomatic subjects with or without a family history","volume":"166","author":"Powell","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21260","article-title":"Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases","volume":"44","author":"Falize","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1373\/clinchem.2005.048371","article-title":"Comparison of the unsaturated iron binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101, 168 participants in the HEIRS study","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.revmed.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2003-10-3564","article-title":"Hemochromatosis mutations in the general population: iron overload progression rate","volume":"103","author":"Andersen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2008.05.004_bib23","first-page":"829","article-title":"Genetic screening for iron overload: no evidence of discrimination at 1 year","volume":"56","author":"Hall","year":"2007","journal-title":"J Fam Pract"},{"key":"10.1016\/j.revmed.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.3748\/wjg.v13.i35.4690","article-title":"Non-HFE haemochromatosis","volume":"13","author":"Wallace","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.revmed.2008.05.004_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0016-5085(02)80116-0","article-title":"A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation","volume":"122","author":"Gochee","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2008.05.004_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10620-006-3210-3","article-title":"Individuals homozygous for the H63D mutation have significantly elevated iron indexes","volume":"51","author":"Samarasena","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.revmed.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2006.07.009","article-title":"The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis","volume":"4","author":"Walsh","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2008.05.004_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0168-8278(02)00042-9","article-title":"Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights","volume":"36","author":"Lor\u00e9al","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2008.05.004_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(96)06034-5","article-title":"A new syndrome of liver iron overload with normal transferrin saturation","volume":"349","author":"Moirand","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.05.004_bib31","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diacare.28.8.2061","article-title":"Prevalence of body iron excess in the metabolic syndrome","volume":"28","author":"Bozzini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2008.05.004_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0016-5085(99)70401-4","article-title":"Insulin resistance-associated hepatic iron overload","volume":"117","author":"Mendler","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2008.05.004_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1309\/WWNE-KW2C-4KTW-PTJ5","article-title":"Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patents","volume":"116","author":"Turlin","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.revmed.2008.05.004_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.05.004_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2008.05.004_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0168-8278(01)00147-7","article-title":"Venesection therapy of insulin resistance-associated hepatic iron overload","volume":"35","author":"Guillygomarc\u2019h","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2008.05.004_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-139-10-200311180-00029","article-title":"Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people","volume":"139","author":"Haap","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2008.05.004_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/eje.1.02083","article-title":"Association between serum ferritin and the insulin resistance syndrome in a representative population","volume":"154","author":"Wrede","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2008.05.004_bib39","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc06-0093","article-title":"Insulin Resistance Syndrome (DESIR) Study Group. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study","volume":"29","author":"Fumeron","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2008.05.004_bib40","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/aje\/kwk093","article-title":"A prospective study of plasma ferritin level and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"165","author":"Jehn","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.revmed.2008.05.004_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diabres.2007.02.004","article-title":"Study of iron metabolism disturbances in an animal model of insulin resistance","volume":"77","author":"Le Guenno","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.revmed.2008.05.004_bib42","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.gastro.2006.07.007","article-title":"Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH","volume":"131","author":"Bekri","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2008.05.004_bib43","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/j.gastro.2006.10.046","article-title":"Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome","volume":"131","author":"Laine","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2008.05.004_bib44","first-page":"S374","article-title":"L\u2019absorption intestinale du fer est diminu\u00e9e dans la surcharge en fer h\u00e9patique associ\u00e9e \u00e0 l\u2019insulino-r\u00e9sistance","volume":"28","author":"Ruivard","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2008.05.004_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2008.05.004_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1478-3231.2004.0988.x","article-title":"Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome","volume":"24","author":"Piperno","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.revmed.2008.05.004_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.99.7.852","article-title":"Coronary heart disease and iron status: meta-analyses of prospective studies","volume":"99","author":"Danesh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2008.05.004_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.297.6.603","article-title":"Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial","volume":"297","author":"Zacharski","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2008.05.004_bib49","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/CIRCULATIONAHA.105.545350","article-title":"Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women","volume":"113","author":"Van der","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2008.05.004_bib50","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc05-2471","article-title":"Common presence of non-transferrin-bound iron among patients with type 2 diabetes","volume":"29","author":"Lee","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2008.05.004_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diabetes.51.4.1000","article-title":"Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function","volume":"51","author":"Fernandez-Real","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.revmed.2008.05.004_bib52","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.3748\/wjg.v13.i35.4755","article-title":"Pathology of hepatic iron overload","volume":"13","author":"Deugnier","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.revmed.2008.05.004_bib53","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJM198212303072703","article-title":"Magnetic-susceptibility measurement of human iron stores","volume":"307","author":"Brittenham","year":"1982","journal-title":"N Engl J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308006279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308006279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:23:22Z","timestamp":1759335802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866308006279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0248866308006279"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2008.05.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surcharges en fer d\u2019origine g\u00e9n\u00e9tique et h\u00e9patosid\u00e9rose dysm\u00e9tabolique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2008.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}